Article

Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications

2020-10-05

Abstract excerpt

Severe coronavirus disease 2019 (COVID-19) has been associated with certain preexisting health conditions and can cause respiratory failure along with other multi-organ injuries. However, the mechanism of these relationships is unclear, and prognostic biomarkers for the disease and its systemic complications are lacking. This study aims to examine the plasma protein profile of COVID-19 patients and evaluate overla...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 69ced5dd-0e42-50a9-9457-9e75a32ff151
DOI: 10.1101/2020.10.02.20205609

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complicationsDOI 10.1101/2020.10.02.20205609Read

Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID-19 patients with pre-existing co-morbiditiesSemantic proximity Read

COVID-19 Mortality is Associated with Impaired Innate Immunity in Pre-existing Health ConditionsSemantic proximity Read

Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditionsSemantic proximity Read

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read

An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID-19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management StrategiesSemantic proximity Read

Clinical phenotypes and features of the post-COVID syndrome courseSemantic proximity Read

COVID-19 severity is associated with immunopathology and multi-organ damageSemantic proximity Read

Plasma proteomics identify potential severity biomarkers from COVID‐19 associated networkSemantic proximity Read

<strong></strong>An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management StrategiesSemantic proximity Read

Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico.Semantic proximity Read

COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data modelSemantic proximity Read

Potential Genes Associated with COVID-19 and Comorbidity.Semantic proximity Read